Significant Scientific Agreement Standard Should Be "Flexible," Cmte. Says
This article was originally published in The Tan Sheet
Executive Summary
The significant scientific agreement standard used to determine the merit of a health claim should be "flexible," a final report by FDA's Food Advisory Committee Working Group on Significant Scientific Agreement/ Totality of Evidence states. The report was endorsed by the full committee at a meeting in Arlington, Va. June 25.